JF
AVIR icon

Jump Financial’s Atea Pharmaceuticals AVIR Stock Holding History

Jump Financial’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$502K Buy
93,247
+74,134
+388% +$340K 0.01% 1241
2025
Q4 		$68.2K Buy
19,113
+5,106
+36% +$16.2K ﹤0.01% 1855
2025
Q3 		$40.6K Buy
+14,007
New +$47.8K ﹤0.01% 1708
2023
Q1 		– Sell
-60,400
Closed -$291K – 1573
2022
Q4 		$291K Buy
+60,400
New +$306K 0.02% 1066
2021
Q4 		– Sell
-43,100
Closed -$1.51M – 1376
2021
Q3 		$1.51M Buy
43,100
+31,100
+259% +$863K 0.11% 208
2021
Q2 		$258K Buy
12,000
+8,369
+230% +$251K 0.02% 736
2021
Q1 		$224K Buy
+3,631
New +$245K 0.02% 724

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Jump Financial's AVIR Position: Q1 2026 in Review

Jump Financial increased its Atea Pharmaceuticals (AVIR) stake by 388% in Q1 2026, buying an estimated $340K and bringing the position to 93,247 shares worth $502K. The position accounts for 0.01% of the portfolio, ranked #1241.

Jump Financial first reported a position in AVIR in Q1 2021 and has held it in 7 quarters since. The position peaked at $1.51M in Q3 2021. 127 funds tracked by Wall St. Rank hold AVIR as of Q1 2026.

  • Jump Financial held 93,247 shares of Atea Pharmaceuticals worth $502K as of Q1 2026.
  • Jump Financial bought 74,134 Atea Pharmaceuticals shares in Q1 2026, an estimated $340K.
  • Atea Pharmaceuticals made up 0.01% of Jump Financial's portfolio in Q1 2026, its #1241 holding.
  • Jump Financial first reported a position in Atea Pharmaceuticals in Q1 2021 and has held it in 7 quarters since.
  • Jump Financial's Atea Pharmaceuticals position peaked at $1.51M in Q3 2021.
  • 127 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.